Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2018

Feb 05, 2019

SELL
$4.8 - $11.6 $960 - $2,320
-200 Closed
0 $0
Q3 2018

Nov 07, 2018

SELL
$9.05 - $10.95 $905 - $1,095
-100 Reduced 33.33%
200 $0
Q1 2018

May 11, 2018

SELL
$12.65 - $18.85 $96,140 - $143,260
-7,600 Reduced 96.2%
300 $0
Q4 2017

Jan 17, 2018

SELL
$17.45 - $25.6 $20,940 - $30,720
-1,200 Reduced 13.19%
7,900 $17,000
Q3 2017

Oct 17, 2017

BUY
$18.9 - $28.2 $171,990 - $256,620
9,100
9,100 $12,000

Others Institutions Holding PRTK

About Paratek Pharmaceuticals, Inc.


  • Ticker PRTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,862,500
  • Description
  • Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...
More about PRTK
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.